机译:乳腺癌中TP53异常的协调:来自TP53多态性分析,杂合性缺失,甲基化和突变的数据
Department of Experimental Oncology, Cancer Research Institute, Siberian Branch of Russian Academy of Medical Sciences, Tomsk,Russian Federation,Department of Cytology and Genetics, Tomsk State University, Tomsk, Russian Federation;
Department of Cytology and Genetics, Tomsk State University, Tomsk, Russian Federation;
Department of Biochemistry and Molecular Biology, Siberian State Medical University, Tomsk, Russian Federation;
Department of Experimental Oncology, Cancer Research Institute, Siberian Branch of Russian Academy of Medical Sciences, Tomsk,Russian Federation;
Department of Experimental Oncology, Cancer Research Institute, Siberian Branch of Russian Academy of Medical Sciences, Tomsk,Russian Federation;
Departments of General Oncology Cancer Research Institute, Siberian Branch of Russian Academy of Medical Sciences, Tomsk, Russian Federation;
Departments of 5Head and Neck Oncology, Cancer Research Institute, Siberian Branch of Russian Academy of Medical Sciences, Tomsk, Russian Federation;
Department of Experimental Oncology, Cancer Research Institute, Siberian Branch of Russian Academy of Medical Sciences, Tomsk,Russian Federation;
机译:缺乏TP53突变的乳腺癌患者中TP53调控途径的甲基化概况和mtDNA改变。
机译:缺乏TP53突变的乳腺癌患者TP53调控途径的甲基化概况和mtDNA改变
机译:TP53突变作为特异性癌症的潜在预后标志物:分析来自癌症基因组地图集的数据和癌症TP53数据库的国际研究机构
机译:PIK3CA,TP53,CDH1基因突变与乳腺癌的相关性分析
机译:rs1042522 TP53(Arg72Pro)多态性的遗传关联研究中的基因型错误分类:对乳腺癌,肺癌,结直肠癌,卵巢癌和子宫内膜癌研究的系统评价
机译:检测乳腺癌细针抽吸物中TP53突变杂合性缺失和DNA含量。
机译:缺乏TP53突变的乳腺癌患者TP53调控途径的甲基化概况和mtDNA改变